C. A. Higley

Follow

Person

Newark, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
Peptidase-cleavable, targeted antineoplastic drugs and their therap...
- Patent number 6,844,318
- Issue date Jan 18, 2005
- Bristol-Myers Squibb Pharma Company
- Robert A. Copeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused-ring heterocycles for the treatment of atherosclerosis
- Patent number 5,478,830
- Issue date Dec 26, 1995
- The Du Pont Merck Pharmaceutical Company
- C. Anne Higley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazoles for the treatment of atherosclerosis
- Patent number 5,318,984
- Issue date Jun 7, 1994
- The Du Pont Merck Pharmaceutical Company
- Jeffrey T. Billheimer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazoles for the treatment of atherosclerosis
- Patent number 5,310,748
- Issue date May 10, 1994
- The Du Pont Merck Pharmaceutical Company
- Richard G. Wilde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzimidazoles for the treatment of atherosclerosis
- Patent number 5,290,801
- Issue date Mar 1, 1994
- The Du Pont Merck Pharmaceutical Company
- C. Anne Higley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of imidazoles for the treatment of atherosclerosis
- Patent number 5,166,214
- Issue date Nov 24, 1992
- Du Pont Merck Pharmaceutical Company
- Jeffrey T. Billheimer
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Peptidase-cleavable, targeted antineoplastic drugs and their therap...
- Publication number 20020103133
- Publication date Aug 1, 2002
- Robert A. Copeland
- C07 - ORGANIC CHEMISTRY